News

Oxford Brain Diagnostics releases Beta version software tool to interpret MRI images for brain degradation analysis (FDA breakthrough device designation)

Oxford Brain Diagnostics releases Beta version software tool to interpret MRI images for brain degradation analysis (FDA breakthrough device designation)
Member News

Oxford Brain Diagnostics is currently developing a new software tool (beta version) for the interpretation of MRI images, pulling together current methods (like brain atrophy) with a new measure that analyses brain degradation at a cellular level. 

The company is looking for clinicians (neurologists, old age psychiatrists, radiologists) interested in learning about this novel way of diagnosis that can predict transition from MCI to Alzheimer’s Disease, and has received FDA breakthrough device designation. 

Discover More

Oxford Brain Diagnostics Ltd is rethinking how brain health is assessed and managed. Founded in neuropathological and neuroimaging expertise, the company’s patented Cortical Disarray Measurement (CDM®) technology uses MRI brain scan data to support early and differential diagnosis, track progression, and predict the decline of neurodegenerative diseases. Oxford Brain Diagnostics is committed to assessing brain health based on changes in the cellular structure, supporting drug development, and helping clinicians around the world in their fight to defeat Alzheimer’s and other neurodegenerative diseases.

For more information please contact Daniel Kaute, Daniel.kaute@oxfordbraindiagnostics.com

NEWS​

Related News

Christabel Pankhurst Institute - Call for seed corn projects 2023 – 2024

30 Nov 2023
The Christabel Pankhurst Institute has been awarded a second round of funds to support a number of seed corn projects.

Accelerating Reform Fund for adult social care: guidance for local authorities

30 Nov 2023
The Department of Health and Social Care (DHSC) is launching the Accelerating Reform Fund (ARF)

Improving cancer services: Cancer Innovation Award Scheme now open

30 Nov 2023
Applications are now open and will close at noon on Friday 1 December 2023

Funding Support Service: Industry and Innovation

30 Nov 2023
Workstream(s): Signpost and Direct Innovators to Further Support or Market Access

Call for partners: novel cybersecurity for medical devices and healthcare IT

29 Nov 2023
Re:lock, a milepoint partner startup, is looking for development partners for a novel cybersecurity solution

CataloniaBio & HealthTech: The organisation that represents companies in the biomedicine and health sector in Catalonia

29 Nov 2023
Discover more about CataloniaBio & HealthTech: The newest member to join our global community

Become a member

Join ECHAlliance to amplify your organisation’s message, grow your networks, connect with innovators and collaborate globally.
 
First name *
Last Name *
Email Address *
Country *
Position *
First name *
Last Name *
Email Address *
Country *
Position *